Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells.

Green TL, Santos MF, Ejaeidi AA, Craft BS, Lewis RE, Cruse JM.

Exp Mol Pathol. 2014 Aug;97(1):44-8. doi: 10.1016/j.yexmp.2014.05.003. Epub 2014 May 14.

PMID:
24836676
2.

Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.

Santos MF, Mannam VK, Craft BS, Puneky LV, Sheehan NT, Lewis RE, Cruse JM.

Exp Mol Pathol. 2014 Jun;96(3):367-74. doi: 10.1016/j.yexmp.2014.04.001. Epub 2014 Apr 13.

PMID:
24731923
3.

Expression of Toll-like receptors by neonatal leukocytes.

Dasari P, Zola H, Nicholson IC.

Pediatr Allergy Immunol. 2011 Mar;22(2):221-8. doi: 10.1111/j.1399-3038.2010.01091.x. Epub 2010 Nov 5.

PMID:
21054549
4.

Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

Sánchez-Muñoz F, Fonseca-Camarillo G, Villeda-Ramírez MA, Miranda-Pérez E, Mendivil EJ, Barreto-Zúñiga R, Uribe M, Bojalil R, Domínguez-López A, Yamamoto-Furusho JK.

BMC Gastroenterol. 2011 Dec 20;11:138. doi: 10.1186/1471-230X-11-138.

5.

Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.

Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.

J Med Virol. 2008 Jun;80(6):980-8. doi: 10.1002/jmv.21174.

PMID:
18428149
6.

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.

Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF.

Immunology. 2010 Mar;129(3):363-74. doi: 10.1111/j.1365-2567.2009.03179.x. Epub 2009 Nov 16.

7.

Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer.

Hong X, Dong T, Hu J, Yi T, Li W, Zhang Z, Lin S, Niu W.

Int J Colorectal Dis. 2013 Jan;28(1):25-33. doi: 10.1007/s00384-012-1530-7. Epub 2012 Jul 10.

PMID:
22777000
8.

Src kinases are required for a balanced production of IL-12/IL-23 in human dendritic cells activated by Toll-like receptor agonists.

Kuka M, Baronio R, Valentini S, Monaci E, Muzzi A, Aprea S, De Gregorio E, D'Oro U.

PLoS One. 2010 Jul 9;5(7):e11491. doi: 10.1371/journal.pone.0011491.

9.

Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells.

Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A.

J Immunol. 2000 Jun 1;164(11):5998-6004.

10.

Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.

Vanhoutte F, Paget C, Breuilh L, Fontaine J, Vendeville C, Goriely S, Ryffel B, Faveeuw C, Trottein F.

Immunol Lett. 2008 Feb 15;116(1):86-94. doi: 10.1016/j.imlet.2007.11.014. Epub 2007 Dec 17.

PMID:
18166232
11.

Toll-like receptors and agonist responses in the developing fetal sheep lung.

Hillman NH, Moss TJ, Nitsos I, Kramer BW, Bachurski CJ, Ikegami M, Jobe AH, Kallapur SG.

Pediatr Res. 2008 Apr;63(4):388-93. doi: 10.1203/PDR.0b013e3181647b3a.

PMID:
18356744
12.

Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease.

Szebeni B, Veres G, Dezsofi A, Rusai K, Vannay A, Bokodi G, Vásárhelyi B, Korponay-Szabó IR, Tulassay T, Arató A.

J Pediatr Gastroenterol Nutr. 2007 Aug;45(2):187-93.

PMID:
17667714
13.

The expression of Toll-like receptors in murine Müller cells, the glial cells in retina.

Lin X, Fang D, Zhou H, Su SB.

Neurol Sci. 2013 Aug;34(8):1339-46. doi: 10.1007/s10072-012-1236-1. Epub 2012 Dec 4.

14.

Leukocyte toll-like receptor expression in end-stage kidney disease.

Gollapudi P, Yoon JW, Gollapudi S, Pahl MV, Vaziri ND.

Am J Nephrol. 2010;31(3):247-54. doi: 10.1159/000276764. Epub 2010 Jan 15.

PMID:
20090311
15.

Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.

Howell J, Sawhney R, Testro A, Skinner N, Gow P, Angus P, Ratnam D, Visvanathan K.

Liver Transpl. 2013 Oct;19(10):1099-107. doi: 10.1002/lt.23712.

17.
18.
19.

Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.

Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR.

Cardiovasc Res. 2006 Dec 1;72(3):384-93. Epub 2006 Sep 23.

PMID:
17054926
20.

Injury primes the innate immune system for enhanced Toll-like receptor reactivity.

Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, Mannick JA, Lederer JA.

J Immunol. 2003 Aug 1;171(3):1473-83.

Supplemental Content

Support Center